CareLit · DOI-Nachweis · Klinische Pädiatrie
RNA Interference Screening to Identify Novel Therapeutic Targets
DOI 10.1055/s-0030-1270310
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Potratz, P Sorensen
ZeitschriftKlinische Pädiatrie
Ausgabe12/2010
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
RNA interference (RNAi) technology provides a powerful tool to study the function of genes and their encoded proteins and has opened up exciting avenues towards therapeutic target discovery. To test the RNAi screening methodology in high-risk childhood sarcoma, we have developed a small-interfering RNA (siRNA) screening assay in two Ewing sarcoma cell lines. In Ewing sarcoma, as in many other cancers, the insulin-li…
Zitieren
Zitierempfehlung
J Potratz, P Sorensen (2010) RNA Interference Screening to Identify Novel Therapeutic Targets. Klinische Pädiatrie (12). https://doi.org/10.1055/s-0030-1270310
Mit CareLit weiterarbeiten